4.8 Article

The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Aβ generation in vivo

Journal

EMBO JOURNAL
Volume 25, Issue 2, Pages 432-443

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.emboj.7600938

Keywords

A beta; Alzheimer; cholesterol; neurodegeneration; therapy

Ask authors/readers for more resources

The cholesterol-synthesizing enzyme seladin-1, encoded by the Dhcr24 gene, is a flavin adenine dinucleotide-dependent oxidoreductase and regulates responses to oncogenic and oxidative stimuli. It has a role in neuroprotection and is downregulated in affected neurons in Alzheimer's disease (AD). Here we show that seladin-1-deficient mouse brains had reduced levels of cholesterol and disorganized cholesterol-rich detergent-resistant membrane domains (DRMs). This was associated with inefficient plasminogen binding and plasmin activation, the displacement of beta-secretase ( BACE) from DRMs to APP-containing membrane fractions, increased beta-cleavage of APP and high levels of A beta peptides. In contrast, overexpression of seladin-1 increased both cholesterol and the recruitment of DRM components into DRM fractions, induced plasmin activation and reduced both BACE processing of APP and A beta formation. These results establish a role of seladin-1 in the formation of DRMs and suggest that seladin-1-dependent cholesterol synthesis is involved in lowering A beta levels. Pharmacological enhancement of seladin-1 activity may be a novel A beta-lowering approach for the treatment of AD.

Authors

Anonymous

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available